World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 93 959 872 528 472 270 36057
Medicine 93 10786 10131 5549 5130 284 36191

John L. Sullivan publications per year

The chart shows the history of publications by John L. Sullivan between 1956 and 2022, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John L. Sullivan published across 67 years, from 1956 to 2022, averaging 4.1 papers a year. Output peaked at 15 publications in 1987. 8 of the 278 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1956 to 2022. Vertical axis: number of publications, 0 to 15. Peak 15 publications in 1987. 1956: 1 publication 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 1 publication 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 1 publication 1972: 1 publication 1973: 0 publications 1974: 0 publications 1975: 3 publications 1976: 5 publications 1977: 5 publications 1978: 3 publications 1979: 1 publication 1980: 7 publications 1981: 7 publications 1982: 4 publications 1983: 4 publications 1984: 8 publications 1985: 10 publications 1986: 4 publications 1987: 15 publications 1988: 3 publications 1989: 12 publications 1990: 11 publications 1991: 8 publications 1992: 6 publications 1993: 9 publications 1994: 9 publications 1995: 7 publications 1996: 10 publications 1997: 14 publications 1998: 5 publications 1999: 11 publications 2000: 9 publications 2001: 9 publications 2002: 7 publications 2003: 9 publications 2004: 8 publications 2005: 5 publications 2006: 3 publications 2007: 2 publications 2008: 5 publications 2009: 4 publications 2010: 3 publications 2011: 4 publications 2012: 2 publications 2013: 3 publications 2014: 1 publication 2015: 1 publication 2016: 3 publications 2017: 4 publications 2018: 2 publications 2019: 1 publication 2020: 0 publications 2021: 7 publications 2022: 1 publication
1956 2022

278 publications in total across all disciplines

View publications per year as a table
John L. Sullivan: publications per year, 1956 to 2022
Year Publications
1956 1
1957 0
1958 0
1959 0
1960 1
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 1
1972 1
1973 0
1974 0
1975 3
1976 5
1977 5
1978 3
1979 1
1980 7
1981 7
1982 4
1983 4
1984 8
1985 10
1986 4
1987 15
1988 3
1989 12
1990 11
1991 8
1992 6
1993 9
1994 9
1995 7
1996 10
1997 14
1998 5
1999 11
2000 9
2001 9
2002 7
2003 9
2004 8
2005 5
2006 3
2007 2
2008 5
2009 4
2010 3
2011 4
2012 2
2013 3
2014 1
2015 1
2016 3
2017 4
2018 2
2019 1
2020 0
2021 7
2022 1
Total 278
Download as CSV

John L. Sullivan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John L. Sullivan sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 262–271 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 270 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116 270
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

John L. Sullivan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John L. Sullivan sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72 93
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John L. Sullivan is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research primarily spans the field of Social Sciences, with particular focus on Communication, Sociology and Political Science, and Literature and Literary Theory.

The main topics of their work include Social Media and Politics, Media Studies and Communication, Digital Marketing and Social Media, Radio, Podcasts, and Digital Media, as well as Literature, Film, and Journalism Analysis.

The recent papers authored by John L. Sullivan are:

  • Audiences (2020), published in The Blackwell Encyclopedia of Sociology
  • GET WITH THE PROGRAM: PROGRAMMATIC ADVERTISING AND THE DATAFICATION OF PODCAST AUDIENCES (2023), published in AoIR Selected Papers of Internet Research

Frequent publication venues for their work include:

  • The Blackwell Encyclopedia of Sociology
  • AoIR Selected Papers of Internet Research

There are no frequently listed co-authors associated with their publications in the provided data.

In 2013, John L. Sullivan was recognized as a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

    Wenhui Li;Michael J. Moore;Natalya Vasilieva;Jianhua Sui

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • Severe herpesvirus infections in an adolescent without natural killer cells.

    Christine A. Biron;Kevin S. Byron;John L. Sullivan

  • Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

    Frank Kirchhoff;Thomas C. Greenough;Doreen B. Brettler;John L. Sullivan

  • Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

    Rhoda S. Sperling;David E. Shapiro;Robert W. Coombs;John A. Todd

  • Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

    D D Richman;D Havlir;J Corbeil;D Looney

  • Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

    Antonia Kwan;Roshini S. Abraham;Robert Currier;Amy Brower

  • Clinical Spectrum of Lymphoproliferative Disorders in Renal Transplant Recipients and Evidence for the Role of Epstein-Barr Virus

    Douglas W. Hanto;Glauco Frizzera;David T. Purtilo;Kiyoshi Sakamoto

  • Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

    Mark E. Sharkey;Ian Teo;Thomas Greenough;Natalia Sharova

  • Proposed definitions for in utero versus intrapartum transmission of HIV-1.

    Y J Bryson;K Luzuriaga;J L Sullivan;D W Wara

  • Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

    Alejandro Dorenbaum;Coleen K. Cunningham;Richard D. Gelber;Mary Culnane

  • A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

    Dhayendre Moodley;Jagidesa Moodley;Hoosen Coovadia;Glenda Gray

  • High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

    Diane Havlir;Sarah H. Cheeseman;Margaret Mclaughlin;Robert Murphy

  • Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo

    Donna Hochberg;Jaap M. Middeldorp;Michelle D. Catalina;John L. Sullivan

  • Infectious mononucleosis.

    Unknown

  • ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

    L A Pinto;J Sullivan;J A Berzofsky;M Clerici

  • Deficient natural killer cell activity in x-linked lymphoproliferative syndrome

    John L. Sullivan;Kevin S. Byron;Frank E. Brewster;David T. Purtilo

  • Frequency of 'Chronic Active Epstein-Barr Virus Infection' in a General Medical Practice

    Dedra Buchwald;John L. Sullivan;Anthony L. Komaroff

  • High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

    Roberto Mariani;Frank Kirchhoff;Frank Kirchhoff;Thomas C. Greenough;John L. Sullivan

  • Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

    Katherine Luzuriaga;Yvonne J. Bryson;Paul A. Krogstad;James E. Robinson

  • Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses

    Katherine Luzuriaga;Margaret M. McManus;Michelle D. Catalina;Shane Renee Mayack

  • Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.

    Kitchen Lw;Barin F;Sullivan Jl;Sullivan Jl;McLane Mf

  • Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates

    Mark Mirochnick;Terry Fenton;Paul Gagnier;Joseph W. Pav

  • Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset

    Emily M. Mace;Emily M. Mace;Amy P. Hsu;Linda Monaco-Shawver;George Makedonas;George Makedonas

  • Activated lymphocytes during acute Epstein-Barr virus infection.

    Blake E. Tomkinson;David K. Wagner;David L. Nelson;John L. Sullivan

  • Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.

    Wenhui Li;Thomas C. Greenough;Michael J. Moore;Natalya Vasilieva

  • Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection

    Louis Alexander;Emma Weiskopf;Thomas C. Greenough;Nathan C. Gaddis

Frequent Co-Authors

Katherine Luzuriaga
Katherine Luzuriaga University of Massachusetts Chan Medical School
Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Frank Kirchhoff
Frank Kirchhoff University of Ulm
Dennis Panicali
Dennis Panicali Harvard University
David T. Purtilo
David T. Purtilo University of Nebraska Medical Center
Richard D. Gelber
Richard D. Gelber Harvard University
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
David A. Thorley-Lawson
David A. Thorley-Lawson Tufts University
Liisa K. Selin
Liisa K. Selin University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your credentials through related healthcare degrees can open diverse career opportunities. Many professionals transition into advanced nursing roles that complement their scientific background. For instance, acute care nurse practitioner programs offer specialized training to provide high-level care in critical settings, important for immunocompromised patients.

If you are an RN aiming to fast-track your career, accelerated programs like those highlighted in accelerated RN to NP programs provide efficient pathways to becoming a Nurse Practitioner, allowing you to blend clinical expertise with immunology knowledge.

For individuals without a nursing background, the best route into the field might include starting with foundational qualifications. The best online BSN programs for non nurses are designed to equip students with essential nursing skills, ideal for integrating immunology concepts with patient care.

Additionally, many find that accelerated nursing programs offer accessible entry points into the nursing profession, allowing students to quickly gain credentials that support various immunology-related clinical roles.

Best Scientists Citing John L. Sullivan

Trending Scientists

Recently Published Articles